Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis
-
- Donald S.A. McLeod
- Department of Internal Medicine & Aged Care, Royal Brisbane and Women's Hospital, Herston, Australia.
-
- David S. Cooper
- Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
-
- Paul W. Ladenson
- Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
-
- Kenneth B. Ain
- Department of Internal Medicine, Veterans Affairs Medical Center and University of Kentucky, Lexington, Kentucky.
-
- James D. Brierley
- Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada.
-
- Henry G. Fein
- Division of Endocrinology and Metabolism, Sinai Hospital, Baltimore, Maryland.
-
- Bryan R. Haugen
- Division of Endocrinology, Metabolism, and Diabetes, University of Colorado School of Medicine, Aurora, Colorado.
-
- Jacqueline Jonklaas
- Division of Endocrinology, Department of Medicine, Georgetown University Medical Center, Washington, District of Columbia.
-
- James Magner
- Genzyme Corporation, Cambridge, Massachusetts.
-
- Douglas S. Ross
- Thyroid Unit, Massachusetts General Hospital, Boston, Massachusetts.
-
- Monica C. Skarulis
- Diabetes, Endocrinology, Obesity Branch, National Institutes of Health, Bethesda, Maryland.
-
- David L. Steward
- Department of Head and Neck Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio.
-
- Harry R. Maxon
- Department of Nuclear Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio.
-
- Steven I. Sherman for the National Thyroid Ca
- Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
収録刊行物
-
- Thyroid
-
Thyroid 24 (1), 35-42, 2014-01
Mary Ann Liebert Inc